Fortress Biotech, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Fortress Biotech, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q1 2019 to Q2 2024.
  • Fortress Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending June 30, 2024 was $2.97M, a 7.02% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.97M -$224K -7.02% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.24M -$331K -9.27% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $3.54M -$344K -8.87% Dec 31, 2023 10-K 2024-03-28
Q3 2023 $3.19M -$688K -17.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.19M Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $3.57M Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.88M +$638K +19.7% Dec 31, 2022 10-K 2023-03-31
Q3 2022 $3.88M Sep 30, 2022 10-Q 2022-11-14
Q4 2021 $3.24M +$48K +1.5% Dec 31, 2021 10-K 2022-03-28
Q4 2020 $3.19M +$56K +1.79% Dec 31, 2020 10-K/A 2021-04-09
Q3 2020 $3.19M +$106K +3.44% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $3.19M +$106K +3.44% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.14M +$53K +1.72% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.14M Dec 31, 2019 10-K 2020-03-16
Q3 2019 $3.08M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $3.08M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.08M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.